Business / Finance

RSS

New ACD European subsidiary aims to provide faster, enhanced support for local customers

Advanced Cell Diagnostics Inc., a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, has announced the establishment of a European subsidiary which will start business in October 2014.

From Advanced Cell Diagnostics 16 Sep 2014

Danaher signs definitive transaction agreement with Nobel Biocare

Danaher Corporation has entered into a definitive transaction agreement with Nobel Biocare Holding AG pursuant to which Danaher Corporation or one of its direct or indirect subsidiaries ("Danaher") will commence a tender offer for all publicly held registered shares of Nobel Biocare in an all-cash transaction valued at approximately $2.2 billion.

From Danaher 15 Sep 2014

ChromaDex signs NIAGEN supply agreement with Healthy Directions

ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it has entered into an ingredient supply agreement with Healthy Directions, a direct-to-consumer nutritional supplement retailer and wholly-owned subsidiary of Helen of Troy Limited.

11 Sep 2014

NSF, NIH, USDA receive more than $12 million in new EEID grants

Ebola, MERS (Middle East Respiratory Syndrome), malaria, antibiotic-resistant infections: Is our interaction with the environment somehow responsible for their increased incidence?

11 Sep 2014

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.

11 Sep 2014

Beta-O2 receives grant from JDRF to study ßAir bio-artificial pancreas for treatment of T1D

Beta-O2 announced today that it has received a $500K grant from JDRF. The grant will be used to help fund a $1M pilot human study of Beta-O2's ßAir bio-artificial pancreas, in development as a treatment and potential cure for type 1 diabetes (T1D).

10 Sep 2014

Lucideon announces collaboration with Knight Mechanical Testing

Lucideon, an international provider of materials development, testing and assurance, and Knight Mechanical Testing, an independent mechanical testing laboratory, are pleased to announce that they have entered into a Marketing and Commercial Collaboration Agreement. The agreement means that both partners will now be to offer a complete portfolio of testing and analysis services to the orthopaedic industry.

From Lucideon 10 Sep 2014

Kinex Pharmaceuticals acquires QuaDPharma

Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., a Western New York based privately-held company specializing in pharmaceutical manufacturing, analytical and support services to the pharmaceutical and biotech industries. Financial terms of the transaction were not disclosed.

9 Sep 2014

Triple-S Salud collaborates with Voxiva and TracFone Wireless to improve health, satisfaction

Triple-S Salud has partnered with TracFone Wireless, Inc. and Voxiva, Inc. to improve the health and satisfaction of their members by providing access to free cell phones and health messaging programs.

8 Sep 2014

Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company's PulseRider® in Europe, the Middle East and Africa.

8 Sep 2014

BMC receives grant from Cardinal Health Foundation to help improve effectiveness of patient care

The Cardinal Health Foundation announced it has awarded Virginia R. Litle, MD, a Thoracic Surgeon at Boston Medical Center (BMC) grant funding from the E3 Grant Program to implement best practices and help improve the effectiveness, efficiency and excellence of patient care.

8 Sep 2014

Three Clemson startup companies receive $25,000 in seed money from USAP

Clemson University Research Foundation (CURF) announced that three Clemson startup companies have each received $25,000 in seed money from the University Sponsored Application Program (USAP) offered by SC Launch.

8 Sep 2014

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company’s PulseRider in Europe, the Middle East and Africa.

8 Sep 2014

TCC enters into merger with TLCC

Twinlab Consolidated Holdings, Inc. and Twinlab Consolidation Corporation announced today that they have entered into an agreement to merge in a stock-for-stock transaction with an anticipated closing date of September 15, 2014.

5 Sep 2014

LSDF announces $750,000 in Proof of Concept grants to promote health-related technologies

The Life Sciences Discovery Fund (LSDF) today announced nearly $750,000 in Proof of Concept grants to Washington state for-profit and non-profit organizations to promote translation of health-related technologies from the laboratory to the commercial marketplace.

4 Sep 2014

Pacific Edge signs agreement with SCPMG to evaluate Cxbladder User Program

Pacific Edge Ltd, a cancer diagnostics company, has signed an agreement with Southern California Permanente Medical Group (SCPMG) to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente's health care network.

3 Sep 2014

Infinity and AbbVie enter into global collaboration to develop and commercialize duvelisib

Infinity Pharmaceuticals, Inc. and AbbVie Inc. today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer.

3 Sep 2014

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

CleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding the development of two new products.

3 Sep 2014

Aviv acquires assisted living and skilled nursing facilities for $83.6 million

Aviv REIT, Inc. announced today it acquired four post-acute and long-term care skilled nursing facilities ("SNF") in Washington, an assisted living facility ("ALF") in Washington and a campus in Idaho, which includes a SNF and an ALF, for a total price of $83.6 million.

2 Sep 2014

BioLegend acquires shares of Covance Antibody Services

BioLegend, Inc. (BioLegend) acquired the shares of Covance Antibody Services Inc., a business unit of Covance, located in Dedham, Massachusetts, on August 29, 2014.

From BioLegend 2 Sep 2014

Business / Finance

New ACD European subsidiary aims to provide faster, enhanced support for local customers

Danaher signs definitive transaction agreement with Nobel Biocare

ChromaDex signs NIAGEN supply agreement with Healthy Directions

NSF, NIH, USDA receive more than $12 million in new EEID grants

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

Beta-O2 receives grant from JDRF to study ßAir bio-artificial pancreas for treatment of T1D

Lucideon announces collaboration with Knight Mechanical Testing

Kinex Pharmaceuticals acquires QuaDPharma

Triple-S Salud collaborates with Voxiva and TracFone Wireless to improve health, satisfaction

Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

BMC receives grant from Cardinal Health Foundation to help improve effectiveness of patient care

Three Clemson startup companies receive $25,000 in seed money from USAP

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

TCC enters into merger with TLCC

LSDF announces $750,000 in Proof of Concept grants to promote health-related technologies

Pacific Edge signs agreement with SCPMG to evaluate Cxbladder User Program

Infinity and AbbVie enter into global collaboration to develop and commercialize duvelisib

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

Aviv acquires assisted living and skilled nursing facilities for $83.6 million

BioLegend acquires shares of Covance Antibody Services

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News